Answers are grounded in this paper and cite their sources.
These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
No takes yet. Share an insight, caveat, or question.
Jones et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: